GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Interest Income

Argos Therapeutics (FRA:77AA) Interest Income : €0.07 Mil (TTM As of Sep. 2018)


View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Argos Therapeutics's interest income for the three months ended in Sep. 2018 was €0.02 Mil. Its interest income for the trailing twelve months (TTM) ended in Sep. 2018 was €0.07 Mil.

Argos Therapeutics Interest Income Historical Data

The historical data trend for Argos Therapeutics's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Interest Income Chart

Argos Therapeutics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Interest Income
Get a 7-Day Free Trial Premium Member Only 0.01 0.05 0.02 0.05 0.05

Argos Therapeutics Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.02 0.02 0.02

Argos Therapeutics Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Argos Therapeutics (FRA:77AA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Interest Income
Comparable Companies
PTEO NSPX CTBO PRTX BOM:524604 GWSN CBDC ATMS HSTC AKAOQ XSAT:EURI B CAPS MBVXQ TSXV:PBS WAR:PFM TIKRF BOM:506365 BOM:532041 GOVX BOM:524796
Traded in Other Exchanges
N/A
Address
4233 Technology Drive, Durham, NC, USA, 27704
Website
http://www.argostherapeutics.com
Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines